No Data
No Data
Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer
Kaskela Law LLC Announces Investigation of EFFECTOR Therapeutics, Inc. (EFTR) and Encourages Former EFFECTOR Employees to Contact the Firm
Express News | EFFECTOR Therapeutics - Oxford Notice Indicates Obligations Under Loan and Security Agreement Shall Accrue Interest at Default Rate
Express News | EFFECTOR Therapeutics Inc - Oxford Notice Indicates That All Obligations Are Now Immediately Due and Payable
Express News | EFFECTOR Therapeutics- Got Notice From Oxford Finance, Events of Default Occurred With Respect to Loan,Security Agreement Dated as of March 19, 2021
EFFECTOR Therapeutics Declared in Default on $75M Oxford Finance Loan
Trytosaveabit : Now if they don’t pay immediately? The interest rate and penalties go really high!
Jaguar8 OP Trytosaveabit : Oh yes $75M is no joke esp their cash burn is higher than their market cap. This company is in trouble.
Trytosaveabit Jaguar8 OP : Big trouble! Hehehe! BTW. Did you see in the Rivian chat the SS that tried to correct you! Well I corrected him and got no reply! Why dont you give it a peak and tell me ifn I did good with ( all the correct ) info! Hehehe
Jaguar8 OP Trytosaveabit : Of course I did! Thank you for expounding! You are the best!
Trytosaveabit Jaguar8 OP : Ifn you gonna correct, and brag to boot! At least include all the pertinent information! Hehehe! Always got your back brother
View more comments...